Companies Rallybio
Rallybio (RLYB): executive pay, fiscal 2024
Free brief. Every figure links to the company’s own filing.
Email me Rallybio’s executive pay brief as a PDF
It arrives in about 2 minutes, with every figure cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $1,765,084FY2023
- $1,127,666FY2024
CEO total pay was $1,127,666 in fiscal 2024, down from $1,765,084 in fiscal 2023.
FY2024: salary $551,200 · bonus $0 · stock awards $0 · option awards $314,626
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Stephen Uden | $551,200 | $0 | $0 | $314,626 | $248,040 | $0 | $13,800 | $1,127,666 |
| Chief Executive Officer and President | ||||||||
| Martin Mackay | 551,200 | 0 | 0 | 314,626 | 223,236 | 0 | 13,800 | 1,102,862 |
| Chairman, former Executive Chairman | ||||||||
| Steven Ryder | 531,227 | 0 | 0 | 174,792 | 191,242 | 0 | 13,800 | 911,061 |
| Chief Medical Officer | ||||||||
| Jonathan Lieber | 478,400 | 0 | 0 | 174,792 | 172,224 | 0 | 13,800 | 839,216 |
| Chief Financial Officer and Treasurer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Stephen Uden | $1,127,666 | $1,765,084 | — | ↓ −637,418 |
| Martin Mackay | 1,102,862 | 1,765,084 | — | ↓ −662,222 |
| Steven Ryder | 911,061 | 1,253,641 | — | ↓ −342,580 |
| Jonathan Lieber | 839,216 | 1,899,030 | — | ↓ −1,059,814 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Compensation Committee generally grants options annually to executives and seeks to make such grants on or around the same date each year. The Committee does not grant equity-based awards in anticipation of the release of material nonpublic information and does not time the disclosure of material nonpublic information for purposes of affecting the value of executive compensation.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2024
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Steven Ryder | RSU | 2,110 | — | $2,026 |
| Stephen Uden | RSU | 5,680 | — | 5,453 |
| Martin Mackay | RSU | 5,680 | — | 5,453 |
| Stephen Uden | Option | 18,084 | 15.04 | — |
| Martin Mackay | Option | 18,084 | 15.04 | — |
| Steven Ryder | Option | 18,084 | 15.04 | — |
| Stephen Uden | Option | 23,334 | 13 | — |
| Martin Mackay | Option | 23,334 | 13 | — |
| Steven Ryder | Option | 23,334 | 13 | — |
| Steven Ryder | Option | 64,459 | 6.5 | — |
| Jonathan Lieber | Option | 95,000 | 1.86 | — |
| Steven Ryder | Option | 95,000 | 1.86 | — |
| Stephen Uden | Option | 115,917 | 6.5 | — |
| Martin Mackay | Option | 115,917 | 6.5 | — |
| Jonathan Lieber | Option | 130,000 | 6.81 | — |
| Stephen Uden | Option | 171,000 | 1.86 | — |
| Martin Mackay | Option | 171,000 | 1.86 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Paula SoteropoulosIndependent · Lead Independent Director · Compensation (Chair) | $70,000 | — | $23,981 | — | — | $93,981 |
| Helen M. BoudreauIndependent · Audit (Chair) | 55,000 | — | 23,981 | — | — | 78,981 |
| Ronald HuntIndependent · Nominating and Corporate Governance · Audit | 51,500 | — | 23,981 | — | — | 75,481 |
| Robert HopfnerIndependent · Nominating and Corporate Governance · Audit | 51,500 | — | 23,981 | — | — | 75,481 |
| Kush M. ParmarIndependent · Departed during FY | 48,000 | — | 23,981 | — | — | 71,981 |
| Hui LiuIndependent · Audit | 47,500 | — | 23,981 | — | — | 71,481 |
| Christine A. NashIndependent · Nominating and Corporate Governance (Chair) · Compensation | 45,000 | — | 23,981 | — | — | 68,981 |
| Wendy K. ChungIndependent · Nominating and Corporate Governance | 44,000 | — | 23,981 | — | — | 67,981 |
| Lucian IancoviciIndependent · Compensation | 0 | — | 0 | — | — | — |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 10,000 / 8,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $412,500 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $412,500 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Rallybio as a peer
Companies that benchmark against RLYB
2 companies name RLYB as a compensation peer
- Astria Therapeutics, Inc.ATXSFY2024
- KYNTRA BIO, INC.FGENFY2025
Each company listed discloses RLYB in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named RLYB in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Rallybio | 2024 | Stephen Uden | $551,200 | $0 | $314,626 | $248,040 | $1,127,666 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (16 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Stephen Uden. DEF 14A, filed 2025-04-07. Section “Executive Compensation”. As printed: 1,127,666. View filing ↗
- Section 01, Martin Mackay. DEF 14A, filed 2025-04-07. Section “Executive Compensation”. As printed: 1,102,862. View filing ↗
- Section 01, Steven Ryder. DEF 14A, filed 2025-04-07. Section “Executive Compensation”. As printed: 911,061. View filing ↗
- Section 01, Jonathan Lieber. DEF 14A, filed 2025-04-07. Section “Executive Compensation”. As printed: 839,216. View filing ↗
- Section 08, Paula Soteropoulos. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 93,981. View filing ↗
- Section 08, Helen M. Boudreau. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 78,981. View filing ↗
- Section 08, Ronald Hunt. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 75,481. View filing ↗
- Section 08, Robert Hopfner. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 75,481. View filing ↗
- Section 08, Kush M. Parmar. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 71,981. View filing ↗
- Section 08, Hui Liu. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 71,481. View filing ↗
- Section 08, Christine A. Nash. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 68,981. View filing ↗
- Section 08, Wendy K. Chung. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: 67,981. View filing ↗
- Section 08, Lucian Iancovici. DEF 14A, filed 2025-04-07. Section “Director Compensation”. As printed: —. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 412,500 + equity 0 + all other 0 = 412,500, summed across the director compensation table rows.
- Rallybio (subject), Section 10b CEO total. DEF 14A, filed 2025-04-07. CEO total compensation as printed in Rallybio's own proxy. As printed: 1,127,666. View filing ↗